Publications

Want to be in the know about the latest advances in diabetes research? Need more information on how to live well with T1D? Connect with us on social networking sites, subscribe to our emails, and check out our print and online materials.



Countdown

  • Study Aims to Preserve Kidney Damage for T1D

    A promising JDRF-funded trial looks at allopurinol—a 50-year-old gout treatment drug—to slow or stop loss of kidney function in people living with Type 1 Diabetes (T1D) The Preventing Early Renal Function Loss in Diabetes (PERL) Consortium is conducting a multi-site, international clinical trial of allopurinol as an intervention for T1D-related kidney disease. Allopurinol is an […]

    Read More

  • JDRF Top Research Advances

    The past year brought about significant advances in type 1 diabetes (T1D) therapies that are improving how people live with the disease and bringing us closer to a biological cure and universal advances that have helped make this a pivotal moment in the history of T1D research. ENCAPSULATION The JDRF Encapsulation Program funds development of […]

    Read More

  • Well-Timed AP Technology Offers Peace of Mind in the UK

    A JDRF-funded study at the University of Cambridge showed that an overnight treat-to-range device improved glucose control A recent JDRF-funded study at the University of Cambridge has found that unsupervised, at-home use of a treat-to-range artificial pancreas system can improve blood-glucose control throughout the night and into the next day. You can click on the […]

    Read More

  • Elizabeth Roosevelt: Ready to share your story with Congress? I am!

    Hello. My name is Elizabeth Roosevelt. I am 12 years old and finishing up the 6th grade. I was diagnosed with type 1 diabetes (T1D) shortly after my fifth birthday. I had been drinking lots of water and using the restroom frequently, but we had no idea what was causing me to feel so badly until […]

    Read More

  • Two-year $300 Million Special Diabetes Program Extended

    In an overwhelming vote, the U.S. Senate approved a two-year extension of the Special Diabetes Program (SDP)—an initiative that accounts for roughly one-third of all federally-funded type 1 diabetes (T1D) research in the United States. “JDRF staff and our network of advocacy leaders and passionate volunteers all across the U.S. work tirelessly every day to […]

    Read More